-
Mashup Score: 2Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD) - 2 year(s) ago
AbstractObjectives. Methotrexate (MTX), leflunomide (LEF) and sulfasalazine (SSZ) are conventional synthetic disease-modifying drugs (csDMARDs) with a well-esta
Source: OUP AcademicCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Biologic DMARDs control ICI-associated inflammatory arthritis quicker than methotrexate - 2 year(s) ago
Patients with immune checkpoint inhibitor-associated inflammatory arthritis who receive a biologic DMARD demonstrate quicker arthritis control, but also experience faster cancer progression, vs. methotrexate, according to data.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
Patients with immune checkpoint inhibitor-associated inflammatory arthritis who receive a biologic #DMARD demonstrate quicker arthritis control, but also experience faster #cancer progression, vs. methotrexate #RheumTwitter @lovetolearn27 https://t.co/WNymqUddFW
-
-
Mashup Score: 0Pneumonia Risk in Patients on DMARD, Glucocorticoid Therapy for Rheumatoid Arthritis - 2 year(s) ago
DMARDs are the most commonly used treatment for patients with rheumatoid arthritis but have been linked with pneumonia and other pulmonary infections.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
https://t.co/0VMReJAL83 #rheumatoidarthritis #DMARD https://t.co/wOhNLhKIhZ
-
-
Mashup Score: 2
Introduction Rheumatoid arthritis (RA) is an autoimmune disease, characterized by chronic and systemic inflammation. Besides, it is known that RA patients may present several comorbidities, such as sarcopenia, a condition where patients present both muscle mass and muscle quality impairment. RA treatment is mostly pharmacological and consists in controlling systemic inflammation and disease…
Source: BioMed CentralCategories: Latest Headlines, RheumatologyTweet-
RT @DrAiLynTan: #DMARD have no effect on #muscle mass in #rheumatoidarthritis 👉🏽https://t.co/WTQETHaion by @hein_thales et al via @Arthrit…
-
-
Mashup Score: 0
Introduction Rheumatoid arthritis (RA) is an autoimmune disease, characterized by chronic and systemic inflammation. Besides, it is known that RA patients may present several comorbidities, such as sarcopenia, a condition where patients present both muscle mass and muscle quality impairment. RA treatment is mostly pharmacological and consists in controlling systemic inflammation and disease…
Source: BioMed CentralCategories: Latest Headlines, RheumatologyTweet-
#DMARD have no effect on #muscle mass in #rheumatoidarthritis 👉🏽https://t.co/WTQETHaion by @hein_thales et al via @ArthritisRes https://t.co/X3GwtXZkDi
-
-
Mashup Score: 0Upadacitinib efficacious in patients with ankylosing spondylitis refractory to biologics - 3 year(s) ago
Upadacitinib is efficacious over 14 weeks in patients with ankylosing spondylitis who mounted poor responses to biologic disease-modifying antirheumatic drugs, according to data published in the Annals of the Rheumatic Diseases. “Overall, treatment options for [axial spondyloarthritis] remain limited compared with other rheumatic diseases such as rheumatoid arthritis (RA) or psoriatic
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
.@HealioRheum: #Upadacitinib is efficacious over 14 weeks in patients with ankylosing spondylitis who mounted poor responses to biologic disease-modifying antirheumatic drugs #DMARD @LUMC_Leiden https://t.co/CiDqJFdUXI
-
-
Mashup Score: 0Upadacitinib efficacious in patients with ankylosing spondylitis refractory to biologics - 3 year(s) ago
Upadacitinib is efficacious over 14 weeks in patients with ankylosing spondylitis who mounted poor responses to biologic disease-modifying antirheumatic drugs, according to data published in the Annals of the Rheumatic Diseases. “Overall, treatment options for [axial spondyloarthritis] remain limited compared with other rheumatic diseases such as rheumatoid arthritis (RA) or psoriatic
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
#Upadacitinib is efficacious over 14 weeks in patients with ankylosing spondylitis who mounted poor responses to biologic disease-modifying antirheumatic drugs #DMARD @LUMC_Leiden https://t.co/yIT8ZEoAh0
-
-
Mashup Score: 1‘More work to be done’: DMARD use remains low in older adults with rheumatoid arthritis - 3 year(s) ago
Despite guidelines recommending early and aggressive therapy in rheumatoid arthritis, disease-modifying antirheumatic drug adoption for older patients remains low, according to data published in ACR Open Rheumatology.
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
Despite guidelines recommending early and aggressive therapy in #rheumatoidarthritis, #DMARD adoption for older patients remains low #RheumTwitter @UMich https://t.co/jkraUHPUpf
-
Despite guidelines recommending early and aggressive therapy in #rheumatoidarthritis, #DMARD adoption for older patients remains low #RheumTwitter @UMich https://t.co/GE11zaIJgo
-
-
Mashup Score: 0
Nurse-led education for patients with rheumatoid arthritis or spondyloarthritis, who are beginning biologic disease-modifying antirheumatic drugs, is effective at changing behaviors to prevent adverse events, according to data.“Biologic disease-modifying antirheumatic drugs (bDMARDs) are effective treatments for inflammatory arthritis but can lead to safety issues, which could be prevented
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
"Hence, delivering a patient education session may be useful to patients starting a first bDMARD," the authors wrote. #DMARD #rheumatoidarthritis #RheumTwitter https://t.co/5SJkNM3fvu
-
-
Mashup Score: 1The undifferentiated arthritis dilemma: the story continues - Nature Reviews Rheumatology - 3 year(s) ago
Undifferentiated arthritis (UA) was redefined by the introduction of the 2010 rheumatoid arthritis (RA) classification criteria. But UA is more than just not having RA — it is about selecting the right patients for DMARD treatment even before diagnosis, and about protecting those with self-limiting disease from potential drug toxicity.
Source: NatureCategories: Latest Headlines, RheumatologyTweet-
#AprilIssue | #NewsandViews from @DanielAletaha Undifferentiated #arthritis is more than not having RA — it is about selecting patients for #DMARD treatment before diagnosis, and protecting those with self-limiting disease from drug toxicity. https://t.co/bVzbuZnUc5 https://t.co/b967WXXTtU
-
NEW results from the NOR-DMARD study evaluate adverse events & #DMARD discontinuation in the real 🌍: ⭐ Discontinuation ⬆ for #leflunomide & #sulfasalazine vs #methotrexate ⭐ Non-medical aspects play a role in acceptance of AEs 📖 👇 https://t.co/oW6d8u3rod https://t.co/Hm3iaHZ8h4